Site Logo
  • Contact Us
  • LinkedIn
  • Twitter
  • About Stoke
    • Overview
    • Leadership
    • Founders
    • Corporate Responsibility
  • Scientific Platform
    • Overview
    • TANGO
    • Publications
  • Disease Areas
    • Overview
    • Dravet Syndrome
    • ADOA
    • SYNGAP1
    • Pipeline
  • Patients & Families
    • Overview
    • Clinical Studies
      • Expanded Access Policy
    • Educational Resources
  • Careers & Culture
    • Overview
    • Job Opportunities
    • Diversity, Inclusion & Belonging
  • Investors & News
    • Overview
    • Media Room
    • Press Releases
    • Events & Presentations
    • Financials & SEC Filings
    • Stock Information
    • Analyst Coverage
    • Governance
    • Settlement Information
  • About Stoke
    • Overview
    • Leadership
    • Founders
    • Corporate Responsibility
  • Scientific Platform
    • Overview
    • TANGO
    • Publications
  • Disease Areas
    • Overview
    • Dravet Syndrome
    • ADOA
    • SYNGAP1
    • Pipeline
  • Patients & Families
    • Overview
    • Clinical Studies
      • Expanded Access Policy
    • Educational Resources
  • Careers & Culture
    • Overview
    • Job Opportunities
    • Diversity, Inclusion & Belonging
  • Investors & News
    • Overview
    • Media Room
    • Press Releases
    • Events & Presentations
    • Financials & SEC Filings
    • Stock Information
    • Analyst Coverage
    • Governance
    • Settlement Information
  • Contact Us
  • Home
  • Scientific Platform
  • Publications
  • Featured Publications

Natural History of Children and Adolescents With Dravet Syndrome: A 24-Month Follow-Up

Topic: Featured Publications

Natural History of Children and Adolescents With Dravet Syndrome: A 24-Month Follow-Up

Neurology

November 14, 2025

View Article

Antisense oligonucleotides increase Scn1a expression and reduce seizures and SUDEP incidence in a mouse model of Dravet syndrome

Science Translational Medicine

August 26, 2020

Read Full Article

Antisense oligonucleotide modulation of non-productive alternative splicing upregulates gene expression

Nature Communications

July 9, 2020

Read Full Article
  • About Stoke
  • Scientific Platform
  • Disease Areas
  • Patients & Families
  • Careers & Culture
  • Investors & News
  • Contact Us
Stoke Logo

© 2026 Stoke Therapeutics, all rights reserved.

  • Privacy Policy
  • Terms of Use
  • Cookie Policy
  • Sitemap
  • LinkedIn
  • Twitter